Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01060553
Other study ID # PPO 09-258
Secondary ID
Status Completed
Phase N/A
First received January 29, 2010
Last updated April 6, 2015
Start date July 2010
Est. completion date December 2011

Study information

Verified date August 2014
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine if acupuncture improves Post-Traumatic Stress Disorder symptoms among veterans who participated in Operations Enduring Freedom and Iraqi Freedom. This study will also examine the degree of veteran acceptance for acupuncture.


Description:

Project Background: Acupuncture can be effective for many of the specific co-morbidities that make up war-related Trauma Spectrum Disorder in both TBI and PTSD patients, including pain, stress and anxiety, insomnia, somatic and post-operative pain. Recent studies find very large effect sizes (Cohen's D .85 to 1.4). Thus, there is good reason to believe that acupuncture will induce recovery across a number of trauma spectrum dysfunctions in patients with TBI and PTSD, at low cost and with little risk.

Project Objectives: The overall objective of this application is to determine the efficacy of adjunctive acupuncture for improving quality of life and function and alleviating co-morbidities associated with TBI and PTSD in service members injured in the current wars. The primary hypothesis of this study is: OIF/OEF veterans who screen positive for TBI or PTSD and are treated with a 12 week standard individualized acupuncture method will experience improved HRQL (as measured by the Veteran's SF-36) at 6, 12 and 24 week follow-up, compared to veterans randomly assigned to standard care alone.

Project Methods: This is a pilot study on veterans who screen positive for TBI or PTSD in the VA healthcare record, which is being submitted to obtain additional pilot data, confirmation of recruitment strategies, and information on non-participants . Frequency distribution and summary statistics for demographics and baseline variables will be presented by intervention group and for all subjects combined. Key demographic variables to be summarized are: age, gender, time to deployment, number of deployments, and diagnosis. Key baseline variables are: PTSD CAPS score, VSF-36, and ANAM score.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria:

- Diagnosis or positive screen test for PTSD.

- Combat veterans of Operation Iraqi Freedom or Operation Enduring Freedom conflicts.

Exclusion Criteria:

- Unable to travel to East Orange VA for 12 consecutive weeks, biweekly for treatment.

- Does not speak English.

- Acupuncture or CBT treatment within the previous six months.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Other:
Acupuncture treatment
This project was initially designed as a randomized trial with one group receiving treatment and the other wait list control, with delayed treatment. Due to extremely high dropout and cancellations and failure to return for post assessment, a midpoint assessment was added. Analysis was done on pre and post measures of all subjects who completed at least the midpoint assessment. Due to the very small number of subjects in the wait list control, the ones who completed 6 or 12 weeks of acupuncture after the wait list were combined with the few who completed the initial acupuncture for a pre-post single group analysis. for those who completed both the 6 and 12 week measures, the latest one was selected for analysis

Locations

Country Name City State
United States East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ East Orange New Jersey

Sponsors (2)

Lead Sponsor Collaborator
VA Office of Research and Development Samueli Institute for Information Biology

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary SF-36 global health functioning Mental component (MCS) and Physical component (PCS) subscales range from 0 to 100 with 100 being better; 50 is expected population average. baseline, 6 or 12 weeks (latest available is used) No
Secondary Pittsburgh Sleep Index subscales range from 0 to 3 with higher being worse. baseline, 6 or 12 weeks (latest available is used) No
See also
  Status Clinical Trial Phase
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Withdrawn NCT00641173 - Early Intervention for Post Traumatic Stress Disorder (PTSD) N/A
Completed NCT00564317 - KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka Phase 3
Recruiting NCT02512445 - Trauma Informed Guilt Reduction Therapy N/A
Completed NCT00100490 - Immune and Endocrine Function in Post-Traumatic Stress Disorder N/A
Terminated NCT03605342 - Optimal Treatment of Veterans With PTSD and Comorbid OUD Phase 2
Terminated NCT02824445 - To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder N/A
Recruiting NCT03152175 - Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators Phase 2
Completed NCT02080351 - A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident N/A
Completed NCT00974402 - Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings N/A
Recruiting NCT00134446 - Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder Phase 4
Not yet recruiting NCT02384369 - Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder Phase 2
Completed NCT00120250 - Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder Phase 4
Completed NCT00039715 - Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder N/A
Recruiting NCT04368689 - The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD N/A
Completed NCT00227357 - The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration N/A
Completed NCT02927288 - Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy N/A
Completed NCT01278316 - Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study N/A
Completed NCT00778960 - Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder. N/A
Completed NCT00288314 - fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating N/A